January 07, 2025 08:38 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Image: Youtube Screen grab

Saridon, Corex and 326 other combination drugs banned

| @indiablooms | Sep 13, 2018, at 06:47 pm

New Delhi, Sept 13 (IBNS) : The Ministry of Health has banned the production, sale of about 328 fixed dose combinations of drugs (FDCs), including Saridon and Corex, two popular drugs in the country, reports said.

This ban will bring an end to a long legal battle between the ministry and the drug manufacturers. The battle, which has been ongoing since 2016, called for these ‘unsafe’ drugs to be banned.

Around 6,000 drug brands are expected to be affected by this ban, among them popular brands such as Saridon (painkiller), Panderm (skin cream), Lupidiclox (antibiotic), Corex (cough syrup) and several others.

In December 2017, the Supreme Court asked Drugs Technical Advisory Board (DTAB) to intervene in the matter. The DTAB eventually said there was no therapeutic evidence that the ingredients in about 328 of these FDCs cause any harm to people.

The All India Drug Action Network sought the banning of the drugs which were not part of the DTAB report, as these itself accounted for about Rs 2,500 crore of the pharmaceutical market.

 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.